Phong Phu Pharmaceutical JSC (HNX:PPP)
18,400
0.00 (0.00%)
At close: Feb 23, 2026
HNX:PPP Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9,540 | 8,876 | 8,482 | 10,301 | 12,118 |
Short-Term Investments | 35,984 | 31,108 | 23,563 | 16,000 | 6,000 |
Cash & Short-Term Investments | 45,524 | 39,984 | 32,044 | 26,301 | 18,118 |
Cash Growth | 13.85% | 24.78% | 21.84% | 45.16% | 101.10% |
Accounts Receivable | 7,508 | 11,094 | 13,188 | 13,568 | 10,446 |
Other Receivables | 1,784 | 611.26 | 860.07 | 612.57 | 321.78 |
Receivables | 9,292 | 11,705 | 14,048 | 14,181 | 10,768 |
Inventory | 40,064 | 36,899 | 32,000 | 36,759 | 41,533 |
Prepaid Expenses | 287.65 | 387.27 | 241.55 | 157.02 | 192.73 |
Other Current Assets | 1,110 | 2,252 | 1,311 | 1,074 | 163.62 |
Total Current Assets | 96,277 | 91,228 | 79,644 | 78,472 | 70,775 |
Property, Plant & Equipment | 56,184 | 57,498 | 60,464 | 60,239 | 64,374 |
Long-Term Investments | 4,100 | - | - | - | - |
Other Intangible Assets | 16,171 | 16,851 | 17,548 | 18,244 | 18,941 |
Long-Term Deferred Tax Assets | 787.19 | 468.27 | 330.04 | 474.71 | 587.83 |
Other Long-Term Assets | 3,200 | 1,097 | 2,036 | 763.99 | 1,352 |
Total Assets | 176,720 | 167,142 | 160,022 | 158,194 | 156,030 |
Accounts Payable | 10,230 | 13,502 | 11,688 | 12,642 | 16,378 |
Accrued Expenses | 14,299 | 10,963 | 10,912 | 9,175 | 7,455 |
Short-Term Debt | 6,287 | - | - | - | 2,000 |
Current Income Taxes Payable | 1,523 | 1,404 | 1,271 | 2,261 | 896.66 |
Other Current Liabilities | 5,445 | 5,699 | 5,556 | 9,275 | 12,492 |
Total Current Liabilities | 37,785 | 31,567 | 29,426 | 33,354 | 39,222 |
Other Long-Term Liabilities | 205.5 | 217 | 225 | 225 | 225 |
Total Liabilities | 37,990 | 31,784 | 29,651 | 33,579 | 39,447 |
Common Stock | 88,000 | 88,000 | 88,000 | 88,000 | 88,000 |
Additional Paid-In Capital | 2,206 | 2,206 | 2,206 | 2,206 | 2,206 |
Retained Earnings | 48,524 | 45,153 | 40,165 | 34,410 | 26,378 |
Shareholders' Equity | 138,730 | 135,358 | 130,371 | 124,616 | 116,583 |
Total Liabilities & Equity | 176,720 | 167,142 | 160,022 | 158,194 | 156,030 |
Total Debt | 6,287 | - | - | - | 2,000 |
Net Cash (Debt) | 39,237 | 39,984 | 32,044 | 26,301 | 16,118 |
Net Cash Growth | -1.87% | 24.78% | 21.84% | 63.18% | - |
Net Cash Per Share | 3983.98 | 4543.68 | 3641.42 | 2694.95 | 1645.87 |
Filing Date Shares Outstanding | 8.8 | 8.8 | 7.85 | 8.8 | 9.76 |
Total Common Shares Outstanding | 8.8 | 8.8 | 7.85 | 8.8 | 9.76 |
Working Capital | 58,493 | 59,660 | 50,218 | 45,119 | 31,554 |
Book Value Per Share | 15764.74 | 15381.62 | 16605.35 | 14160.89 | 11943.46 |
Tangible Book Value | 122,559 | 118,507 | 112,823 | 106,371 | 97,642 |
Tangible Book Value Per Share | 13927.12 | 13466.74 | 14370.30 | 12087.67 | 10003.03 |
Buildings | 68,337 | 67,996 | 67,996 | - | - |
Machinery | 45,347 | 43,401 | 43,710 | - | - |
Construction In Progress | - | 61.78 | - | 575.07 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.